Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 USD | -1.88% | +21.80% | +1.34% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.34% | 1.41B | |
+22.80% | 47.9B | |
+46.56% | 41.42B | |
-1.92% | 40.7B | |
-6.20% | 28.92B | |
+11.46% | 25.55B | |
-21.18% | 19.27B | |
-1.28% | 12.15B | |
+30.53% | 12.14B | |
-0.72% | 11.99B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : Secures Provisional Marketing Approval for COVID-19 Treatment in Australia